• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Artificial Organs >Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children: A Single Institution Experience
【24h】

Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children: A Single Institution Experience

机译：HeartWare HVAD作为儿童移植的桥梁的早期结果：单一机构的经验

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant (N = 7 cardiomyopathy, N = 1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87%) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6-91 days). All transplanted patients are alive and well at a median follow-up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).
机译：HeartWare HVAD已被用作儿科人群心脏移植的桥梁。我们描述将HeartWare HVAD植入单个中心后的结果。对我们机构在2013年5月至2015年3月间进行的所有HeartWare HVAD植入物进行了回顾性图表审查。8位9至17岁的儿童接受了HVAD植入，以作为移植的桥梁（N = 7心肌病，N = 1复合物）单心室）。复杂的单心室患者有1例手术死亡。 7例患者（87％）成功桥接到移植。支持的中位数时间为24.5天（范围为6-91天）。所有接受移植的患者都还活着，并且平均随访了448天。我们的结果表明，使用HeartWare HVAD进行机械支撑对于大小不一的患者（从大孩子到青少年）都是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号